10 March 2026 Signing of a Memorandum of Understanding between the Egyptian Health Council and Biotechnology Vaccine City
within the framework of the state's keenness to develop the health system and enhance the capabilities of medical cadres. The Egyptian Health Council signed a memorandum of understanding with the Vaccine and Biotechnology City to support the Egyptian Board's programs in the fields of veterinary medicine and pharmacy.
The Egyptian Health Council is represented by prof. Mohamed Lotayef, The Executive president of the Egyptian Health Council, and Mr. Magdy El-Sayed as CEO and Co-Founder of Vaccines and Biotechnology City.
This agreement comes in light of the competencies of the Egyptian Health Council in implementing the programs of the Egyptian Board and setting the controls and standards regulating them, where it was agreed to accredit the headquarters of the Vaccine and Biotechnology City as accredited training centers for the Egyptian Board's programs and continuous professional development activities.
The two parties stressed that the MoU will contribute to the preparation and qualification of highly qualified health cadres, and the development of accredited specialized training programs, in order to enhance the quality of health services and consolidate the concepts of patient safety and continuing medical education, as well as transfer the scientific, technical and training expertise available at the Vaccine and Biotechnology City to the Egyptian Board system.
This cooperation reflects the strategic orientation towards building an integrated health system, capable of keeping pace with global developments in the fields of medical education and scientific research, in order to achieve the maximum benefit from national potentials and enhance Egypt's position in the health sector regionally and internationally.
The signing of the agreement was attended by Prof. Dr. Amr Qandil, Deputy Minister of Health and Population for Preventive Medicine
Major General Dr. Magdy Amin, Chairman of the Board of Directors of the Plasma Products Company
Dr. Hisham Badr, Vice President of the General Authority for Unified Procurement
Dr. Neama Abdel, Representative of the World Health Organization in Egypt
Dr. Tamer El-Husseini, Vice President of the Drug Authority
Major General Veterinarian / Mohsen Azzouz
